DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 209478
» See Plans and Pricing
The generic ingredient in CAROSPIR is spironolactone. There are sixteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the spironolactone profile page.
Summary for 209478
Tradename: | CAROSPIR |
Applicant: | Cmp Dev Llc |
Ingredient: | spironolactone |
Patents: | 4 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209478
Mechanism of Action | Aldosterone Antagonists |
Medical Subject Heading (MeSH) Categories for 209478
Suppliers and Packaging for NDA: 209478
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478 | NDA | ATLANTIC BIOLOGICALS CORP. | 17856-0120 | 17856-0120-1 | 72 CUP in 1 BOX (17856-0120-1) > 2.5 mL in 1 CUP |
CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478 | NDA | CMP Pharma, Inc. | 46287-020 | 46287-020-01 | 473 mL in 1 BOTTLE (46287-020-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 25MG/5ML | ||||
Approval Date: | Aug 4, 2017 | TE: | RLD: | Yes | |||||
Patent: | Start Trial | Patent Expiration: | Oct 28, 2036 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | Start Trial | Patent Expiration: | Oct 28, 2036 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | Start Trial | Patent Expiration: | Oct 28, 2036 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription